Evidence map›Paper›PMID 28433935›Full record

ArticleBiomaterials2017

Distinct ON/OFF fluorescence signals from dual-responsive activatable nanoprobes allows detection of inflammation with improved contrast.

Mathieu L Viger, Guillaume Collet, Jacques Lux, Viet Anh Nguyen Huu, Monica Guma, Alexandra Foucault-Collet, Jason Olejniczak, Shivanjali Joshi-Barr, Gary S Firestein, Adah Almutairi

Abstract read
In one paragraph

Article in Biomaterials, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mathieu L VigerSkaggs School of Pharmacy and Pharmaceutical Sciences, KACST - UCSD Center for Excellence in Nanomedicine and Engineering, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093-0600, USA.
Guillaume ColletSkaggs School of Pharmacy and Pharmaceutical Sciences, KACST - UCSD Center for Excellence in Nanomedicine and Engineering, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093-0600, USA.
Jacques LuxUT Southwestern Medical Center, Department of Radiology, 5323 Harry Hines Blvd., Dallas, TX 75390-8896, USA.
Viet Anh Nguyen HuuDepartment of Nanoengineering, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093-0448, USA.
Monica GumaDivision of Rheumatology, Allergy and Immunology, School of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0656, USA.
Alexandra Foucault-ColletSkaggs School of Pharmacy and Pharmaceutical Sciences, KACST - UCSD Center for Excellence in Nanomedicine and Engineering, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093-0600, USA.
Jason OlejniczakDepartment of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0332, USA.
Shivanjali Joshi-BarrSkaggs School of Pharmacy and Pharmaceutical Sciences, KACST - UCSD Center for Excellence in Nanomedicine and Engineering, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093-0600, USA.
Gary S FiresteinDivision of Rheumatology, Allergy and Immunology, School of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0656, USA.
Adah AlmutairiSkaggs School of Pharmacy and Pharmaceutical Sciences, KACST - UCSD Center for Excellence in Nanomedicine and Engineering, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093-0600, USA. Electronic address: aalmutairi@ucsd.edu.

Funding

VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DIANE M SIMEONE · 1985 to 2026
$124.9M
Tissue Imaging, Biochemistry and MorphologyP01HL091830 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WAGNER, PETER D · 2009 to 2013
$10.1M
Chemically amplified response strategies for medical sciences; concepts borrowedDP2OD006499 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ALMUTAIRI, ADAH · 2009 to 2009
$2.3M
Choline kinase: a novel target for rheumatoid arthritisK08AR064834 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GUMA, MONICA · 2013 to 2017
$687k
IVIS Spectrum Imaging SystemS10RR027970 · NCRR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BREEN, ELLEN C · 2010 to 2010
$401k
NCI NIH HHS P30 CA023100NCRR NIH HHS S10 RR027970NHLBI NIH HHS P01 HL091830NIAMS NIH HHS K08 AR064834NIH HHS DP2 OD006499
6 · The paper itself

Abstract

Visualization of biochemical changes associated with disease is of great clinical significance, as it should allow earlier, more accurate diagnosis than structural imaging, facilitating timely clinical intervention. Herein, we report combining stimuli-responsive polymers and near-infrared fluorescent dyes (emission max: 790 nm) to create robust activatable fluorescent nanoprobes capable of simultaneously detecting acidosis and oxidative stress associated with inflammatory microenvironments. The spectrally-resolved mechanism of fluorescence activation allows removal of unwanted background signal (up to 20-fold reduction) and isolation of a pure activated signal, which enables sensitive and unambiguous localization of inflamed areas; target-to-background ratios reach 22 as early as 3 h post-injection. This new detection platform could have significant clinical impact in early detection of pathologies, individual tailoring of drug therapy, and image-guided tumor resection.

Indexed as

AnimalsFemaleFluorescent DyesHumansInflammationMammary Neoplasms, ExperimentalMiceMolecular ImagingPolymersSpectroscopy, Near-InfraredFluorescent DyesPolymersInflammatory microenvironmentsMolecular imagingNIR optical nanoprobesSpectrally-resolved imagingStimuli-responsive polymers

Identifiers

PMID28433935
PMCPMC5704950

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.